BACKGROUND AND OBJECTIVES:Transforaminal endoscopic diskectomy is an effective approach for treatment of thoracic and lumbar disk pathologies. Classically, intraoperative neuromonitoring is used in these approaches given the risk to the exiting nerve root during transforaminal targeting. The trans-superior articular process (trans-SAP) approach is a targeting technique that docks on the ventrolateral SAP, allowing access to lateral recess pathology. This approach theoretically minimizes risk to the exiting nerve root which could occur with targeting or aberrant reaming. We investigate the safety of the trans-SAP approach by analyzing intraoperative neuromonitoring events in transforaminal endoscopic cases. METHODS:A retrospective analysis of 180 transforaminal endoscopic cases using the trans-SAP approach and free-running electromyography (EMG) neuromonitoring was performed. Cases were performed at 4 institutions; Houston Methodist Hospital, University Of Michigan, University of Washington, and Texas Back Institute, from 2021 to 2024. Neuromonitoring data using free-running EMG were carefully reviewed for each case and adverse monitoring events or EMG triggers were recorded. RESULTS:Free-running EMG neuromonitoring was used in 180 of the 212 reviewed cases (84.91%). No adverse monitoring events or EMG triggers were recorded in 179 of the 180 monitored trans-SAP approach cases (99.44%). Three were performed awake with conscious sedation and no recorded events during targeting. One case was deemed safe without neuromonitoring based on thoracic foraminal pathology without cord compression. In the single case with a neuromonitoring event, multiple episodes of spontaneous neurotonic EMG activity were recorded during the dissection and diskectomy portion of the case, ultimately subsiding. CONCLUSION:The trans-SAP approach for endoscopic diskectomy allows for safe access in transforaminal surgery. There was only one neuromonitoring event during the initial targeting in the 180 monitored or 3 awake trans-SAP cases included in this study that resolved without intraoperative or postoperative symptoms. These results could obviate the need for intraoperative neuromonitoring in these cases.
INTRODUCTION:Posterior lumbar fusion is a widely used technique for stabilizing the lumbar spine, yet complications such as cranial facet violations, increased blood loss, and soft tissue trauma have prompted interest in minimally invasive alternatives. Transfacet screw fixation has emerged as a promising technique, offering advantages such as reduced surgical morbidity, lower risk of adjacent segment degeneration, and greater biomechanical stability in specific patient populations. This study investigates the clinical outcomes of patients undergoing one- or two-level lumbar fusion using transfacet screws. METHODS:A retrospective cohort study was conducted on a consecutive series of 31 patients who underwent posterior lumbar fusion using transfacet screws between 2010 and 2022. Patients were included if they received transfacet or translaminar screw fixation at one or two spinal levels and had a minimum of one-year follow-up. Clinical outcomes were evaluated using Oswestry Disability Index (ODI) scores, visual analog scale (VAS) scores for back and leg pain, and clinical data on reoperation rates and indications were evaluated. RESULTS:The mean age of the study population was 53.3 years (range 26-83), and 54.8% were male. Most patients (71%) involved a combined interbody and posterior fusion. A total of 82 screws were implanted across 41 levels, with 48 being translaminar facet screws and 34 being transfacet screws. Patients experienced significant improvements in ODI (40.1 vs. 23.1; p<0.001), back pain (6.4 vs. 2.7; p<0.001), and leg pain (4.7 vs. 2.3; p=0.003) scores. The overall reoperation rate was 19.4% (n=6), with half of these reoperations addressing preexisting pathology rather than surgical failure. Five of the six reoperations (83.3%) involved the use of transfacet screws at additional levels. Time from index to reoperation was shorter on average for continued symptomatic patients (19.7 months) than those who developed symptoms due to new pathologies (49.7 months). CONCLUSION:This study found that the use of transfacet screw fixation provides a viable alternative to traditional pedicle screws, offering significant pain relief and functional improvement.
OBJECTIVE Prospective spine registries such as the National Neurosurgery Quality and Outcomes Database (N2QOD) have established the value of multicenter outcomes monitoring for quality improvement in spine care. However, conventional registry architectures were designed primarily for long-term benchmarking after traditional fusion procedures, and they remain resource intensive, coordinator dependent, and structurally limited in their capacity to capture the immediate postoperative period. This limitation is particularly consequential for endoscopic and minimally invasive spine surgery, where clinically meaningful recovery unfolds rapidly and predominantly outside the hospital. Endoscopic procedures demand a fundamentally different registry approach: ultra-early measurement of pain, wound status, and function during the front-loaded outpatient recovery arc. Here, the authors evaluated SPINEHealthie, a care-integrated digital platform designed specifically for high-frequency, patient-directed data acquisition during the critical first postoperative weeks after endoscopic spine surgery. METHODS SPINEHealthie is a smartphone application integrating structured patient-reported outcome measures (PROMs), asynchronous patient-provider communication, virtual wound surveillance, and active care delivery. The platform is governed by the Endoscopic Spine Research Group (ESRG), a multicenter consortium of 24 surgeons across 17 IRB-approved institutions. Between 2021 and 2025, 1656 patients were enrolled. The authors analyzed participation rates, PROM compliance, and paired baseline to 3-month outcomes across cervical (n = 156) and thoracolumbar (n = 1500) modules. RESULTS Enrollment feasibility was high: 91.0% of eligible patients participated, with 85.0% completing postoperative PROMs. Sixty-seven percent (67.0%) completed >= 5 PROMs within postoperative week 1; 53.2% submitted wound images. Cumulative data volume reached 142,484 data points. Paired baseline to 3-month outcomes demonstrated consistent improvements across all procedures and both modules. Platform-supported care delivery was associated with reduced clinic utilization and fewer emergency department visits. CONCLUSIONS SPINEHealthie closes a key visibility gap in the early postoperative course after ambulatory endoscopic spine surgery by enabling remote, high-frequency measurement integrated with active care delivery. Conventional registries optimize for long-term benchmarking after traditional spine procedures; SPINEHealthie optimizes for ultra-early outpatient recovery surveillance after tissue-sparing surgery. These findings demonstrate that purpose-built digital registries can meaningfully advance quality improvement and patient safety in endoscopic spine surgery by capturing the rapid-recovery trajectories that traditional systems were not designed to assess.
BACKGROUND CONTEXT Cervical total disc replacement (TDR) has demonstrated outcomes comparable or superior to anterior cervical discectomy and fusion, including reoperation rates. However, a complication unique to TDR is osteolysis, characterized by significant bone loss in the vertebral bodies at the implanted level, which may necessitate revision surgery. PURPOSE To evaluate the occurrence of cervical TDR removal due to osteolysis and identify associated risk factors. STUDY DESIGN/SETTING Retrospective study of a consecutive series from a multisite spine specialty center. PATIENT SAMPLE A total of 2476 patients undergoing cervical TDR beginning in 2003, with a minimum of 12 months postoperative follow-up. OUTCOME MEASURES Incidence of TDR removal or revision due to osteolysis. METHODS Patient records were reviewed to identify cases requiring TDR removal for osteolysis. Variables including age, sex, body mass index (BMI), device type, and number of operated levels were analyzed using stepwise logistic regression to identify factors associated with revision. RESULTS TDR removal due to osteolysis occurred in 23 of 2476 cases (0.9%; 95% CI 0.61%–1.40%). Device type was the only factor significantly associated with revision. Age, sex, BMI, and number of operated levels were not significant predictors. Among 11 device types used, two designs—M6-C and Simplify—demonstrated higher revision rates (8.1% and 4.2%, respectively). The mean time to removal was 36.6 months (range, 9–80 months). In most cases, the TDR was removed and converted to anterior cervical discectomy and fusion (ACDF). In select cases with less severe but progressive osteolysis, the TDR was replaced with a different device. CONCLUSIONS Osteolysis is an uncommon but important complication of cervical TDR, with an overall low incidence. The risk appears to be associated with specific device designs. These findings are consistent with existing literature, though limited sample sizes for certain devices may affect interpretation. FDA Device/Drug Status M6-C, Secure-C, and PCM (approved for single-level use); Simplify, Mobi-C, ProDisc-C, and Prestige (approved for one- and two-level use). No devices are approved for hybrid or multi-level (>2) applications; remaining devices were investigational.